Tal Zvi Zaks
CIK 1690927 · Chief Medical Officer · last filed 2026-06-08
Tal Zvi Zaks is a Chief Medical Officer who has filed 91 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for TEVA, was dated Jun 8, 2026. Across all open-market trades the lifetime net is −$124.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.79M
4
91
-$124.16M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TEVA | Director | 73,264 | $34.63 | $2.54M | $0 | 10 | 2026-06-08 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Director | — | $0.06 | — | $0 | 3 | 2022-07-01 |
| MRNA | Chief Medical Officer | 5,000 | $49.91 | $249.5K | -$124.16M | 74 | 2021-07-02 |
| ASND | Director | — | $218.06 | — | $0 | 4 | 2019-07-03 |
Recent Filings
91 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | TEVA | Exer (M) | +14,492 | $0 | EDGAR |
| 2026-06-01 | TEVA | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | TEVA | Mixed | +9,632 | $0 | EDGAR |
| 2024-06-17 | TEVA | Exer (M) | +21,108 | $0 | EDGAR |
| 2024-06-10 | TEVA | Grant (A) | — | $0 | EDGAR |
| 2023-08-07 | TEVA | Exer (M) | +15,810 | $0 | EDGAR |
| 2023-06-20 | TEVA | Grant (A) | — | $0 | EDGAR |
| 2022-11-07 | TEVA | Exer (M) | +12,205 | $0 | EDGAR |
| 2022-08-08 | TEVA | Grant (A) | — | $0 | EDGAR |
| 2022-07-01 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |